My Companies
Notification
Account
NSE and BSE granted in-principle approval for Mukka Proteins’ proposed issue of 2 crore non-promoter convertible warrants at ₹23.50 each, potentially raising ₹47 crore. Allotment remains subject to regulatory compliance; dilution and capital deployment remain key considerations.
Mukka Proteins Secures CESTAT Relief, Sets Aside ₹15.24 Crore Customs Demand
Mukka Proteins Approves ₹47 Crore Warrant Issue and Two Acquisitions